Articles published by Merck & Co., Inc.
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
June 24, 2025
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs
June 12, 2025
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK

From Merck & Co., Inc.
Via Business Wire
Tickers
MRK



From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces Third-Quarter 2025 Dividend
May 27, 2025
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
April 29, 2025
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK

Merck Announces First-Quarter 2025 Financial Results
April 24, 2025
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK


From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.